This study intends to evaluate the microbiome of chronically constipated patients as compared to those with a non-constipated gastrointestinal system.
Biogeographically accurate microbiome sampling using the HyGIeaCare platform and an evolutionary biology informed learning platform will allow an improved discovery of bacterially derived novel molecular entities with therapeutic potential for chronic constipation. This approach intends to enhance our ability to understand the gut microbiome and use it towards developing therapeutic solutions, in comparison to traditional collection methods and taxonomic-based data analysis approaches.
Study Type
OBSERVATIONAL
Enrollment
30
Stool specimens will be taken before and during the HyGIeaCare procedure. Microbiome comparisons will be made across all specimens
Hygieacare Center - Flowood
Flowood, Mississippi, United States
Hygieacare - Norwood
Cincinnati, Ohio, United States
HyGIeaCare Center
Norfolk, Virginia, United States
Identify the presence of microbial substances within stool samples taken from different locations along the colon
Finding novel molecular entities with therapeutic potential for chronic constipation using the unique HyGIeaCare approach for constipation relief and collection of fecal material for analysis.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.